* Head of the FDA’s pharmaceuticals division Janet Woodcock
says data on sarepta’s DMD drug is particularly hard to
interpret
The post BRIEF-FDA’s Woodcock warns of extreme consequences of not approving drug that works appeared first on NASDAQ.
Forex – financial instrument.Forex news
* Head of the FDA’s pharmaceuticals division Janet Woodcock
says data on sarepta’s DMD drug is particularly hard to
interpret
The post BRIEF-FDA’s Woodcock warns of extreme consequences of not approving drug that works appeared first on NASDAQ.